The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma.
第一作者:
Giulia,Tolomelli
第一单位:
Seràgnoli Institute of Hematology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.;Unit of Hematology, Rimini Hospital "Infermi", Rimini, Italy.
作者:
医学主题词
苄胺类(Benzylamines);粒细胞集落刺激因子(Granulocyte Colony-Stimulating Factor);造血干细胞动员(Hematopoietic Stem Cell Mobilization);造血干细胞移植(Hematopoietic Stem Cell Transplantation);杂环化合物(Heterocyclic Compounds);人类(Humans);多发性骨髓瘤(Multiple Myeloma);移植, 自体(Transplantation, Autologous)
DOI
10.1038/s41409-019-0756-1
PMID
31768009
发布时间
2021-06-21
- 浏览5
Bone marrow transplantation
946-954页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



